The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Transdermal Nicotine for Smoking Cessation: Six-Month Results From Two Multicenter Controlled Clinical Trials
Abstract
Objective. —To evaluate the efficacy of a new transdermal nicotine system for smoking cessation. Design. —Two 6-week, randomized, double-blind, placebo-controlled, parallel group trials were conducted. Successful abstainers from both trials enrolled in a third trial for blinded downtitration from medications (6 weeks) and subsequent off-drug follow-up (12 weeks). Setting. —Nine outpatient clinics specializing in the treatment of smoking cessation. Patients. —Healthy volunteers who smoked one or more packs of cigarettes daily and wanted to participate in a smoking cessation program. Intervention. —Patients were randomly assigned to a transdermal nicotine system delivering nicotine at rates of 21,14, or 7 mg (in trial 1 only) over 24 hours or to placebo. Group counseling sessions were provided to all participants. Main Outcome Measure. —Rates of continuous smoking abstinence were determined during 6 weeks of full-dose treatment, a 6-week weaning period (through week 12), and a 3-month follow-up receiving no therapy (through week 24). Abstinence was defined by patient diary reports of no smoking during the designated periods, confirmed by expired-breath carbon monoxide levels of 8 ppm or lower. Results. —The centers enrolled 935 patients. Cessation rates during the last 4 weeks of the two 6-week trials (pooled data) were 61%, 48%, and 27% for 21-and 14-mg transdermal nicotine and placebo, respectively ( P ≤.001 for each active treatment vs placebo). Six-month abstinence rates for 21-mg transdermal nicotine and placebo were 26% and 12%, respectively ( P ≤.001). All transdermal nicotine doses significantly decreased the severity of nicotine withdrawal symptoms and significantly reduced cigarette use by patients who did not stop smoking. Compliance was excellent, and no serious systemic adverse effects were reported. Conclusions. —Transdermal nicotine systems show considerable promise as an aid to smoking cessation. ( JAMA . 1991;266:3133-3138)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring nicotine dependence: A review of the Fagerstrom Tolerance Questionnaire
Fagerstrom, K. O., & Schneider, N. G. (1989) · Journal of Behavioral Medicine · doi:10.1007/bf00846549 · Cited by 1,598
Pharmacologic Aspects of Cigarette Smoking and Nicotine Addiction
Oates, J. A., Wood, A. J. J., & Benowitz, N. L. (1988) · New England Journal of Medicine · doi:10.1056/nejm198811173192005 · Cited by 971
Kottke, T. E. (1988) · JAMA · doi:10.1001/jama.259.19.2883 · Cited by 741
Review and evaluation of smoking cessation methods : the United States and Canada, 1978-1985
Schwartz, J. L. (1987) · Medical Entomology and Zoology · Cited by 334
Trends in cigarette smoking in the United States. Projections to the year 2000
Pierce, J. P. (1989) · JAMA · doi:10.1001/jama.261.1.61 · Cited by 333
A Double-Blind Trial of a 16-Hour Transdermal Nicotine Patch in Smoking Cessation
Tonnesen, P., Norregaard, J., Simonsen, K., & Säwe, U. (1991) · New England Journal of Medicine · doi:10.1056/nejm199108013250503 · Cited by 295
Severity of withdrawal symptoms as a predictor of outcome of an attempt to quit smoking
West, R. J., Hajek, P., & Belcher, M. (1989) · Psychological Medicine · doi:10.1017/s0033291700005705 · Cited by 279
CONTROLLED TRIAL OF TRANSDERMAL NICOTINE PATCH IN TOBACCO WITHDRAWAL
Abelin, T., Müller, P., Buehler, A., Vesanen, K., & Imhof, P. R. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91671-1 · Cited by 201
META-ANALYSIS OF RANDOMISED CONTROLLED TRIALS OF NICOTINE CHEWING-GUM
Lam, W., Sacks, H., Sze, P., & Chalmers, T. (1987) · The Lancet · doi:10.1016/s0140-6736(87)93061-3 · Cited by 196
Determinants of nicotine intake while chewing nicotine polacrilex gum
Benowitz, N. L., Jacob, P., & Savanapridi, C. (1987) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1987.58 · Cited by 176
Cited by
Nicotine replacement therapy for smoking cessation
Stead, L. F., Perera, R., Bullen, C., Mant, D., Hartmann-Boyce, J., Cahill, K., & Lancaster, T. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000146.pub4 · Cited by 2,464
Nicotine replacement therapy for smoking cessation
Stead, L. F., Perera, R., Bullen, C., Mant, D., & Lancaster, T. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000146.pub3 · Cited by 721
Nicotine replacement therapy versus control for smoking cessation
Hartmann-Boyce, J., Chepkin, S. C., Ye, W., Bullen, C., & Lancaster, T. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000146.pub5 · Cited by 697
The scientific case that nicotine is addictive
Stolerman, I. P., & Jarvis, M. J. (1995) · Psychopharmacology · doi:10.1007/bf02245088 · Cited by 649
Weight gain in smokers after quitting cigarettes: meta-analysis
Aubin, H.-J., Farley, A., Lycett, D., Lahmek, P., & Aveyard, P. (2012) · BMJ · doi:10.1136/bmj.e4439 · Cited by 510
Metadata
- Authors
- Christen, A.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 1991-12-11
- Volume
- 266
- Issue
- 22
- Pages
- 3133
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2128406057
- Cited by
- 297
- References
- 21
- FWCI
- 15.21
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Transdermal Nicotine for Smoking Cessation: Six-Month Results From Two Multicenter Controlled Clinical Trials. https://app.cochat.ai/papers/10.1001/jama.1991.03470220049025
- The paper
- Christen, A. (1991). Transdermal Nicotine for Smoking Cessation: Six-Month Results From Two Multicenter Controlled Clinical Trials. JAMA. https://doi.org/10.1001/jama.1991.03470220049025
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.